In the PC3 tumor cytotoxicity assay, TB725-003 demonstrated robust tumor killing activity, indicating that the addition of binding to hDKK1 CRD1 in a quadrivalent bispecific antibody format can improve tumor suppression (Fig. 5D). This evidence concerns the gene DKK1 and neoplasm.